Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cell Therapeutics, Inc. announced results from a study released by Dartmouth–Hitchcock Medical Center at the International Association for the Study of Lung Cancer 13th World Conference on Lung Cancer. The study demonstrated that in patients with advanced non–small cell lung cancer, the combination of OPAXIO and Alimta was well tolerated and resulted in median progression–free survival of 3.3 months.


Today in Chemotherapy/Oncology...keeping you current

Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer
Annals of Internal Medicine, 11/17/09

Current status of maintenance therapy for advanced ovarian cancer
International Journal of Women's Health, 11/03/09

Adjuvant Chemotherapy in Localized Soft Tissue Sarcomas: Still Not Proven
The Oncologist, 10/28/09

Today in Dosing...keeping you current

Drug dosage protocol for calcium oxalate stone
Urological Research - Urolithiasis, 10/23/09

Risperidone dose for schizophrenia
Cochrane Reviews, 10/21/09

Telavancin: A Novel Lipoglycopeptide
Clinical Infectious Diseases, 11/16/09

Today in Other Drugs...keeping you current

Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09

An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma
American Journal of Medicine, 10/27/09

Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Journal of Clinical Endocrinology and Metabolism, 11/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address